Xolair 产品代理

注射用XOLAIR®（omalizumab）是一种可注射处方药，用于治疗：

6岁及6岁以上哮喘症状未通过哮喘药物吸入糖皮质激素得到很好控制的人群中重度持续性哮喘。进行皮肤或血液测试，看看你是否对全年的过敏原过敏。目前尚不清楚XOLAIR对6岁以下哮喘患者是否安全有效。

当治疗鼻息肉的药物称为鼻皮质类固醇并没有发挥足够的作用时，18岁及以上的人会出现鼻息肉。目前尚不清楚XOLAIR对18岁以下的鼻息肉患者是否安全有效。

慢性自发性荨麻疹（CSU，以前称为慢性特发性荨麻疹（CIU），无已知原因的慢性荨麻疹）发生在12岁及12岁以上的人中，这些人的荨麻疹未通过H1抗组胺治疗得到控制。目前尚不清楚XOLAIR对12岁以下CSU患者是否安全有效。

XOLAIR不用于治疗其他过敏性疾病、其他形式的荨麻疹或突发性呼吸问题。

The XOLAIR prefilled syringe

known if XOLAIR is safe and effective in people with asthma under 6 years of age.

nasal polyps in people 18 years of age and older when medicines to treat nasal polyps called nasal corticosteroids have not worked well enough. It is not known if XOLAIR is safe and effective in people with nasal polyps under 18 years of age.

chronic spontaneous urticaria (CSU, previously referred to as chronic idiopathic urticaria (CIU), chronic hives without a known cause) in people 12 years of age and older who continue to have hives that are not controlled with H1 antihistamine treatment. It is not known if XOLAIR is safe and effective in people with CSU under 12 years of age.

XOLAIR is not used to treat other allergic conditions, other forms of hives, or sudden breathing problems.